Sanen F J, Van Scott E, Bayard S
Int J Clin Pharmacol Biopharm. 1975 Jul;12(1-2):174-9.
Although there is a variety of animal models available, neither a single assay system nor the results of the various assays permit absolute protection of relative anti-inflammatory potency. Equally, current clinical dose titration studies, although more reliable, provide only gross estimates of therapeutic potency when conducted in certain clinical situations in a double-blind randomized fashion. This paper delineated clinical means to titrate more objectively and accurately therapeutic potency in the patient. Moreover, it has submitted considerations as to how to assess therapeutic anti-inflammatory activity in the complex multi-component process of inflammation accompanying most dermatologic diseases that eventually may permit titration of specific anti-inflammatory compounds on certain tissue components of the inflammatory process.
尽管有多种动物模型可用,但无论是单一的检测系统还是各种检测的结果,都无法绝对地确定相对抗炎效力。同样,目前的临床剂量滴定研究虽然更可靠,但在某些临床情况下以双盲随机方式进行时,也只能提供治疗效力的大致估计。本文阐述了在患者中更客观、准确地滴定治疗效力的临床方法。此外,还提出了关于如何在大多数皮肤病伴随的复杂多成分炎症过程中评估治疗性抗炎活性的考虑因素,这最终可能允许在炎症过程的某些组织成分上滴定特定的抗炎化合物。